Urea kinetics and dialysis treatment time predict vancomycin elimination during high-flux hemodialysis

Clinical Pharmacology and Therapeutics

Volumn 63, Issue 1, 1998, Pages 26-38

  Schaedeli, Franziska ^a   Uehlinger, Dominik E ^a  

^a UNIVERSITY OF BERN   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

CELLULOSE ACETATE; POLY(METHYL METHACRYLATE); POLYSULFONE; VANCOMYCIN;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; CREATININE CLEARANCE; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG DETERMINATION; DRUG DOSE; FEMALE; HEMODIALYSIS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN EXPERIMENT; HUMAN TISSUE; INFECTION; INTRAVENOUS DRUG ADMINISTRATION; MALE; MATHEMATICAL MODEL; MEMBRANE FILTER; PRACTICE GUIDELINE; PRIORITY JOURNAL; ULTRAFILTRATION; UREA NITROGEN BLOOD LEVEL;

ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; FEMALE; HUMANS; LINEAR MODELS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; RENAL DIALYSIS; TIME FACTORS; UREA; VANCOMYCIN;

EID: 0031942737     PISSN: 00099236     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0009-9236(98)90118-7     Document Type: Article

References (14)

1. Gotch FA. Kinetic modeling in hemodialysis. In: Nissenson AR, Fine RN, Gentile DE, editors. Clinical dialysis. Norwalk (CT): Appleton & Lange; 1995. p. 156-88.
2. Daugirdas JT. Second generation logarithmic estimates of single-pool variable volume Kt/V: an analysis of error. J Am Soc Nephrol 1993;4:1205-13.
3. Daugirdas JT, Schneditz D. Overestimation of hemodialysis dose depends on dialysis efficiency by regional blood flow but not by conventional two pool urea kinetic analysis. ASAIO J 1995;41:M719-24.
4. [Anonymous]. Morbidity and mortality of renal dialysis: an NIH consensus conference statement. Consensus Development Conference Panel. Ann Intern Med 1994;121:62-70.
5. Tan CC, Lee HS, Ti TY, Lee EJ. Pharmacokinetics of intravenous vancomycin in patients with end-stage renal failure. Ther Drug Monit 1990; 12:29-34.
6. DeSoi CA, Sahm DF, Umans JG. Vancomycin elimination during high-flux hemodialysis: kinetic model and comparison of four membranes. Am J Kidney Dis 1992;20:354-60.
7. Torras J, Cao C, Rivas MC, Cano M, Fernandez E, Montoliu J. Pharmacokinetics of vancomycin in patients undergoing hemodialysis with polyacrylonitrile. Clin Nephrol 1991;36:35-41.
8. Lanese DM, Alfrey PS, Molitoris BA. Markedly increased clearance of vancomycin during hemodialysis using polysulfone dialyzers. Kidney Int 1989;35:1409-12.
9. Quale JM, O Halloran JJ, DeVincenzo N, Barth RH. Removal of vancomycin by high-flux hemodialysis membranes. Antimicrob Agents Chemother 1992;36: 1424-6.
10. Böhler J, Reetze Bonorden P, Keller E, Kramer A, Schollmeyer PJ. Rebound of plasma vancomycin levels after haemodialysis with highly permeable membranes. Eur J Clin Pharmacol 1992;42:635-9.
11. Welage LS, Mason NA, Hoffman EJ, Odeh RM, Dombrouski J, Patel JA, et al. Influence of cellulose triacetate hemodialyzers on vancomycin pharmacokinetics. J Am Soc Nephrol 1995;6:1284-90.
12. Schwenzer KS, Wang CJ, Anhalt JP. Automated fluorescence polarization immunoassay for monitoring vancomycin. Ther Drug Monit 1983;5:341-5.
13. Follin SL, Mueller BA, Scott MK, Carfagna MA, Kraus MA. Falsely elevated serum vancomycin concentrations in hemodialysis patients. Am J Kidney Dis 1996;27:67-74.
14. Najjar TA, Al-Dhuwailie AA, Tekle A. Comparison of high-performance liquid chromatography with fluores